Enrichment for PI3K/AKT/mTOR signaling and loss of PTEN are features described in the GATA3-PTCL subtype of human PTCL-NOS [3, 5]. This evidence concerns the gene GATA3 and mature T-cell and NK-cell non-Hodgkin lymphoma.